Go Pro

Connor Clark & Lunn Investment Management Ltd. Makes New $3.18 Million Investment in Schrodinger, Inc. $SDGR

Schrodinger logo with Healthcare background
Image from MarketBeat Media, LLC.

Connor Clark & Lunn Investment Management Ltd. purchased a new stake in Schrodinger, Inc. (NASDAQ:SDGR - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 195,746 shares of the company's stock, valued at approximately $3,181,000. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.27% of Schrodinger at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in SDGR. BlackRock Inc. acquired a new stake in shares of Schrodinger in the 2nd quarter valued at about $170,978,000. Rubric Capital Management LP raised its stake in Schrodinger by 43.8% during the 1st quarter. Rubric Capital Management LP now owns 6,000,000 shares of the company's stock worth $68,160,000 after buying an additional 1,828,502 shares during the period. Millennium Management LLC boosted its holdings in Schrodinger by 1,075.8% in the third quarter. Millennium Management LLC now owns 1,551,721 shares of the company's stock worth $31,128,000 after acquiring an additional 1,419,750 shares in the last quarter. Lazard Asset Management LLC boosted its holdings in Schrodinger by 65.3% in the third quarter. Lazard Asset Management LLC now owns 2,346,441 shares of the company's stock worth $47,070,000 after acquiring an additional 927,234 shares in the last quarter. Finally, Bank of America Corp DE grew its stake in Schrodinger by 428.3% in the second quarter. Bank of America Corp DE now owns 606,916 shares of the company's stock valued at $12,211,000 after acquiring an additional 492,032 shares during the period. Institutional investors own 79.05% of the company's stock.

Schrodinger Stock Performance

Shares of SDGR opened at $19.70 on Friday. The firm has a market capitalization of $1.45 billion, a P/E ratio of -26.62 and a beta of 1.63. Schrodinger, Inc. has a 52 week low of $10.94 and a 52 week high of $23.02. The stock has a 50 day moving average price of $16.89 and a two-hundred day moving average price of $14.15.

Schrodinger (NASDAQ:SDGR - Get Free Report) last posted its earnings results on Wednesday, August 5th. The company reported $0.08 earnings per share for the quarter, beating analysts' consensus estimates of ($0.41) by $0.49. The company had revenue of $58.89 million for the quarter, compared to analyst estimates of $47.19 million. Schrodinger had a negative return on equity of 16.37% and a negative net margin of 20.98%.The company's revenue for the quarter was up 7.5% on a year-over-year basis. During the same quarter last year, the company earned ($0.65) earnings per share. On average, equities analysts forecast that Schrodinger, Inc. will post -1.89 earnings per share for the current year.

Wall Street Analyst Weigh In

SDGR has been the subject of several recent research reports. Weiss Ratings upgraded Schrodinger from a "sell (e+)" rating to a "sell (d-)" rating in a report on Thursday. Morgan Stanley reduced their price target on shares of Schrodinger from $19.00 to $17.00 and set an "equal weight" rating for the company in a research report on Thursday, May 14th. UBS Group initiated coverage on shares of Schrodinger in a report on Friday, August 14th. They set a "neutral" rating and a $19.00 price objective on the stock. Finally, Wall Street Zen raised shares of Schrodinger from a "strong sell" rating to a "hold" rating in a research note on Saturday, August 8th. Three equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $20.50.

Read Our Latest Research Report on Schrodinger

About Schrodinger

(Free Report)

Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.

Featured Stories

Institutional Ownership by Quarter for Schrodinger (NASDAQ:SDGR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Schrodinger Right Now?

Before you consider Schrodinger, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrodinger wasn't on the list.

While Schrodinger currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines